North Bethesda, MD
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)Foundation for the National Institutes of Health Inc, founded in 1996, is a mid-sized nonprofit in the Medical Research sector that reported $61.0M in total revenue in fiscal year 2023. Revenue decreased 14% compared to the prior year. Expenses of $69.6M exceeded revenue, resulting in a 14% operating deficit.
The Foundation for the National Institutes of Health (FNIH) builds public-private partnerships that connect leading biomedical scientists at the National Institutes of Health (NIH) with their counterparts in life sciences companies, academia, patient organizations, foundations, and regulatory agencies (including the Food and Drug Administration and European Medicines Agency). Through team science, the FNIH solves complex health challenges and accelerates breakthroughs for patients, regardless of who they are or what health threats they face. The FNIH contributes to the development of new therapies, diagnostics, and potential cures; advances global health and equity in care; and celebrates and helps train the next generations of scientists. Established by Congress in 1990 to support the mission of the NIH, the FNIH is a not-for-profit 501(c)(3) charitable organization. For more information about the FNIH, please visitfnih.org.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $60,965,788 | $70,585,199 | -0.1% |
| Expenses | $69,644,743 | $77,418,110 | -0.1% |
| Net Income | $-8,678,955 | $-6,832,911 | +0.3% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| N/A | Chief Executive Officer | 40.0 |
Officer
Director
|
$613,755 | $43,274 | $657,029 |
| N/A | Board Member | 0.5 |
Director
|
$0 | $0 | $0 |
| N/A | Board Member | 0.5 |
Director
|
$0 | $0 | $0 |
| N/A | Board Member | 0.5 |
Director
|
$0 | $0 | $0 |
| N/A | Board Member | 0.5 |
Director
|
$0 | $0 | $0 |
| N/A | Board Member | 0.5 |
Director
|
$0 | $0 | $0 |
| N/A | Board Member | 0.5 |
Director
|
$0 | $0 | $0 |
| N/A | Board Member | 0.5 |
Director
|
$0 | $0 | $0 |
| N/A | Board Member | 0.5 |
Director
|
$0 | $0 | $0 |
| N/A | Board Member | 0.5 |
Director
|
$0 | $0 | $0 |
| N/A | Board Member | 0.5 |
Director
|
$0 | $0 | $0 |
| N/A | Vice-Chairman | 0.5 |
Director
|
$0 | $0 | $0 |
| N/A | Chairman | 1.5 |
Director
|
$0 | $0 | $0 |
| N/A | Board Member | 0.5 |
Director
|
$0 | $0 | $0 |
| N/A | Board Member | 0.5 |
Director
|
$0 | $0 | $0 |
| N/A | Board Member | 0.5 |
Director
|
$0 | $0 | $0 |
| N/A | Board Member | 0.5 |
Director
|
$0 | $0 | $0 |
| N/A | Board Member | 0.5 |
Director
|
$0 | $0 | $0 |
| N/A | Board Member | 0.5 |
Director
|
$0 | $0 | $0 |
| N/A | Secretary | 1.0 |
Director
|
$0 | $0 | $0 |
| N/A | Treasurer | 2.0 |
Director
|
$0 | $0 | $0 |
| N/A | Senior Vice President, Chief Growth and Innovation Officer | 40.0 |
Key Emp
|
$400,911 | $40,224 | $441,135 |
| N/A | Chief Strategy and Business Development (UNTIL NOV.) | 40.0 |
Key Emp
|
$375,609 | $39,802 | $415,411 |
| N/A | Senior Vice President, Chief Financial Officer | 40.0 |
Key Emp
|
$289,166 | $40,393 | $329,559 |
| N/A | Senior Vice President, Chief Translational Science Officer | 40.0 |
Key Emp
|
$324,692 | $39,943 | $364,635 |
| N/A | Chief Strategic Alliances and Advancement Officer (UNTIL NOV.) | 40.0 |
Key Emp
|
$180,943 | $17,503 | $198,446 |
| N/A | Senior Vice President, Chief Operating Officer and General Counsel | 40.0 |
Key Emp
|
$283,492 | $37,823 | $321,315 |
| N/A | Senior Vice President, Chief Population Health Science Officer | 40.0 |
Key Emp
|
$368,742 | $34,416 | $403,158 |
| N/A | Associate Vice President, Science Partnerships Translational Science | 40.0 |
Highest
|
$236,430 | $27,203 | $263,633 |
| N/A | Vice President -Controller | 40.0 |
Highest
|
$231,174 | $32,796 | $263,970 |
| N/A | Vice President of Advancement (UNTIL NOV.) | 40.0 |
Highest
|
$220,316 | $20,295 | $240,611 |
| N/A | Associate Vice President, Science Partnerships Translational Science | 40.0 |
Highest
|
$258,208 | $28,555 | $286,763 |
| N/A | Associate Vice President, Science Partnerships Translational Science | 40.0 |
Highest
|
$240,048 | $33,223 | $273,271 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | No data | No data | No data | No data |
| 2023 | $60,965,788 | $69,644,743 | $206,113,368 | $-8,678,955 |
| 2022 | $70,585,199 | $77,418,110 | $216,582,542 | $-6,832,911 |
| 2021 | $107,605,691 | $58,402,636 | $221,939,759 | $49,203,055 |
| 2020 | $100,179,822 | $58,654,356 | $171,939,741 | $41,525,466 |
| 2019 | $53,818,891 | $67,424,608 | $135,541,703 | $-13,605,717 |
| 2018 | $63,457,296 | $42,192,912 | $142,893,974 | $21,264,384 |
Compare Foundation for the National Institutes of Health Inc with other nonprofits in Maryland and across the country.